Join Us for CURE's Educated Patient Updates on Metastatic Breast Cancer! Don't miss this in-person opportunity designed to empower and educate patients about metastatic breast cancer. 📅 Date: Thursday, July 18 🕒 Time: 5:30 PM PT 📍 Location: Irvine, CA Overview: - Gain a comprehensive understanding of metastatic breast cancer and its various subtypes. - Learn about hormone therapy options for ER+/HER2- metastatic breast cancer. - Understand the importance of biomarkers, what they are, and why testing for them is crucial. - Explore a hypothetical patient's treatment journey utilizing practical applications of topics discussed. This event is a valuable opportunity to connect with experts and gain critical knowledge to navigate metastatic breast cancer. In collaboration with: CITY OF HOPE, MEDICAL CENTER & Susan G Komen Register, attend, and complete the brief survey to earn a $50 gift! Reserve your seat today! https://ow.ly/chai50SxcOP #breastcancer #mbc #cancer #metastatic #breastcancerawareness #educatedpatient
About us
Curetoday.com and CURE magazine, our free publication, are the leading resources for patients with cancer, survivors and their caregivers to become empowered advocates in their journeys. We deliver cancer updates, research and education to help make cancer understandable during every stage of the experience and connect the cancer community.
- Website
-
http://www.curetoday.com
External link for CURE Media Group
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Cranbury, New Jersey
- Type
- Privately Held
- Specialties
- books and resource guide, interactive website
Locations
-
Primary
2 Clarke Dr
Cranbury, New Jersey 08512, US
Employees at CURE Media Group
-
Christina Lizaso
Community Engagement Professional; Co-founder #gyncsm
-
Sonya Collins
Independent journalist/editor covering health care & medical research; public speaker & instructor; fluent Portuguese.
-
Curtis Smith
Bussiness Owner
-
Jeremy Pivor
Partnerships & Youth Engagement Director at Bow Seat Ocean Awareness Programs // Healthcare advocate, writer, and speaker
Updates
-
Less than 2 weeks away from CURE's Educated Patient Updates in Metastatic Breast Cancer in person event! When? Thursday, July 18 at 5:30 PT Where? Irvine, CA Agenda? - Understanding metastatic breast cancer and its subtypes - Initial hormone therapy for treatment of ER+/HER2- metastatic breast cancer - Biomarkers: What they are and why we test for them - Next hormone therapy ER+/HER2- metastatic breast cancer that progresses or stops responding - A hypothetical example of a patient's treatment strategy In collaboration with: City of Hope, & Susan G. Komen Reserve your seat today: https://ow.ly/pahm50SrT06
-
-
Join us for this insightful webinar: "Navigating Radiotherapy: Confidence Through Knowledge" on Thursday, July 18, 2024, at 7:00 PM ET and 7:00 PM PT. Expert speaker Dr. Hannah Dahn, Radiation Oncologist, will guide you through types and applications of radiotherapy, debunk fears and misconceptions, and discuss managing treatment side effects. Complete the survey after watching for a chance to win a $200 gift card! Register now at https://ow.ly/nLJP50SpBgm. #Radiotherapy #CancerTreatment #PatientEducation
-
-
We're excited to announce the arrival of CURE® magazine's Summer Issue! Dive into the world of cutting-edge cancer research as we explore the impact of cancer vaccines. Discover how these innovative treatments are significantly reducing melanoma risk and offering new hope to patients. Don't miss our inspiring feature on Gary Keblish, who has achieved lasting remission thanks to the mRNA-4157 vaccine. This issue is packed with informative articles that showcase the latest advancements in cancer care. Whether you're a patient, caregiver, or survivor, CURE® continues to be your trusted source for oncology news and insights. Get your copy today and stay informed about the rapidly evolving landscape of cancer treatment! Visit: https://ow.ly/efW950SsZmS #CancerResearch #CancerVaccines #CancerCare #PatientCare
-
-
Last chance to help us improve CURE through our survey on curetoday.com! We’re conducting a survey to gather feedback from our readers. Your insights will help us enhance our content and better serve the cancer community. Take the survey here: https://lnkd.in/eAz7x_DV Thank you for your valuable input.
-
-
Join CURE, City of Hope, & Susan G. Komen on July 18 at 5:30 PM in Irvine, CA for Educated Patient Updates in Metastatic Breast Cancer. Hear from breast cancer experts and connect with fellow nurses, patients, survivors, and caregivers. Knowledge you'll walk away with includes: - Understanding metastatic breast cancer and its subtypes - Initial hormone therapy for treatment of ER+/HER2- metastatic breast cancer - Biomarkers: What they are and why we test for them - Next hormone therapy for ER+/HER2- metastatic breast cancer that progresses or stops responding - A hypothetical example of a patient’s treatment strategy Reserve your seat today: https://ow.ly/pahm50SrT06
-
-
Seeking clarity on your treatment? Don't miss our eye-opening webinar "Navigating Radiotherapy: Confidence Through Knowledge" on Thursday, July 18, 2024 (7:00 PM ET/PT). Renowned Radiation Oncologist Dr. Hannah Dahn will demystify radiotherapy, addressing various techniques, common concerns, and practical strategies for managing side effects. Take advantage of this educational opportunity, answer our quick survey, and you could win a $200 gift card! Secure your spot now: https://ow.ly/i59550Sqp9Q. #RadiationTherapy #CancerCare #PatientEmpowerment
-
-
Your opinion matters! Help us improve CURE Today by sharing your feedback in our survey. It only takes a few minutes! Take the survey now: https://ow.ly/FU4z50SefQB
-
-
CURE Media Group reposted this
Now in its fifteenth year, the Comprehensive Hematology & Oncology Review Course founded by Fred Hutch's Dr. Andrew Coveler is still going strong. Each year, it attracts more than 100 people in-person and more online to learn about guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumor cancers and malignant and nonmalignant hematologic disorders. Read more: https://bit.ly/3KsFODv
-
Make your voice heard! We're committed to delivering the best content for our readers, and we need your help. Share your thoughts in our survey and help us tailor our offerings to better meet your needs. Click here to participate: https://ow.ly/2Bqm50SefiP Thank you for your support!
-